跳至主要内容
临床试验/NL-OMON45737
NL-OMON45737尚未招募不适用

Tumor-derived circulating endothelial cells as a biomarker in locally advanced and metastatic clear cell renal cell carcinoma - RECEC study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Patients with locally advanced or metastatic ccRCC
  • * Candidate for receiving first-line therapy with sunitinib or pazopanib
  • * Age * 18 years
  • * Written informed consent

排除标准

  • * Serious illness or medical unstable condition prohibiting adequate treatment and follow-up
  • * Previous treatment with systemic therapy for ccRCC

研究者

相似试验